Rubicon Research Limited

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about a successful unannounced US FDA inspection of its manufacturing facility in Satara, Maharashtra, India, with only one procedural observation.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance under Regulation 74(5) for the quarter ended September 30, 2026.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange regarding the allotment of 7,200 fully paid-up equity shares of INR 1 each, pursuant to the exercise of employee stock options under the Rubicon Research Limited - Employee Stock Option Scheme 2022, increasing the issued, subscribed and paid-up equity share capital of the Company to INR 16,55,39,108.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the declaration of Unaudited Financial Results for the quarter and half year ending September 30, 2026.

Rubicon Research Limited

Rubicon Research Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 26, 2026, and informed the Exchange regarding voting results.

Rubicon Research Limited

Rubicon Research Limited held its 27th Annual General Meeting on August 26, 2026, through video conferencing, with 71 members in attendance. The meeting was conducted in compliance with relevant laws and regulations, and the requisite quorum was present. The statutory auditor's report and secretarial auditor's report for the year ended March 31, 2026, were taken as read, with no qualifications, reservations, adverse remarks, or disclaimers.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange regarding 'Transcript of Earnings Call Q1 FY 2026-27'. The company's revenue from operations came out to INR534 crores, EBITDA came out at INR131 crores, and PAT came out at around INR85 crores. The company has reported a strong growth in revenue, EBITDA, and PAT, with year-on-year revenue growth of 51%, EBITDA growth of 65%, and PAT growth of more than 95%. The company's ROCE for the quarter was strong at 36%.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in the Financial Express and Loksatta newspapers.

Rubicon Research Limited

Rubicon Research Limited has made available the audio recording of its earnings conference call for the quarter ended June 30, 2026, on its website.

Rubicon Research Limited

Rubicon Research Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its Initial Public Offering (IPO). The report states that there was no deviation from the objects of the issue.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about change in Management, with the Board of Directors approving the appointment of Mr. Rohit Saraogi as Chief Financial Officer (CFO) and the re-appointment of Mr. Venkat Changavalli as Chairman, effective from September 18, 2026.

Rubicon Research Limited

Rubicon Research Limited has released its Q1 FY 2026-27 investor presentation, which includes consolidated financial highlights and a summary income statement. The company has reported a 51.6% year-over-year increase in revenue from operations, with EBITDA and PAT growing by 64.6% and 95.8%, respectively. The company has also provided an update on its balance sheet, with total equity increasing to ₹13,913 million and borrowings rising to ₹3,272 million.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about Investor Presentation. The presentation includes Q1 FY 2026-27 financial highlights, consolidated financial overview, and summary income statement. The company has reported a 51.6% year-over-year growth in revenue from operations, with a 64.6% increase in EBITDA. The presentation also includes a summary balance sheet, which shows a 17.6% increase in total equity and a 36% return on assets before interest and taxes (ROACE).

Rubicon Research Limited

Rubicon Research Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which have been reviewed by the Audit Committee and approved by the Board of Directors. The results show a net profit after tax of ₹824.49 million and a basic earnings per share of ₹4.99.

Rubicon Research Limited

Rubicon Research Limited has issued a corrigendum to its Integrated Annual Report for the financial year 2025-26, correcting minor typographical errors and updating shareholding patterns.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about Earnings Call to discuss the Company’s financial performance for the quarter ended June 30, 2026, and the way forward.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about Copy of Newspaper Publication regarding the 27th Annual General Meeting and Voting Information.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year 2025-26'.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange about a copy of a newspaper publication regarding the 27th Annual General Meeting, e-voting procedure, final dividend, and record date.

Rubicon Research Limited

Rubicon Research Limited has informed the Exchange regarding the tax deduction at source on dividend for the financial year 2025-26. The company has recommended a final dividend of Rs. 1.50 per Equity Share for the financial year ended March 31, 2026, subject to the approval of the shareholders at the ensuing 27th Annual General Meeting.